Creative Medical Technology Holdings Inc. - Rasio total nilai perusahaan marang pendapatan CELZ

Simbol resmi perusahaan Creative Medical Technology Holdings Inc. (CELZ)

Creative Medical Technology is developing the AmnioStem platform by investing in the treatment of urological pathologies. The company's EV/Sales ratio visualizes the business value to sales dynamics, where the value 0.00 reflects the current magnitude. Costly cryogenic cell delivery complicates supply chains, while the absence of commercial products forces the company to rely on existing investment reserves.

Creative Medical Technology Holdings Inc. (CELZ) - Multiplikator EV/Sales saka 23.11.2025 nganti 19.11.2026

CELZ (Creative Medical Technology Holdings): rincian analitis lan laporan miturut indikator

Sampel barang creativemedicaltechnology.com

To assess the financial stability of Creative Medical Technology (CELZ), it is critical to analyze the enterprise value of the business, accounting for net debt relative to sales volume. This EV/Sales metric demonstrates the price of every dollar of revenue, allowing investors to compare current capitalization with the pace of patent commercialization in regenerative medicine and the expansion of the company's clinic network.